| Literature DB >> 28448569 |
Kerstin Jost1,2, Isabelle Pramana2, Edgar Delgado-Eckert3, Nitin Kumar3, Alexandre N Datta4, Urs Frey4, Sven M Schulzke2.
Abstract
BACKGROUND: Poor control of body temperature is associated with mortality and major morbidity in preterm infants. We aimed to quantify its dynamics and complexity to evaluate whether indices from fluctuation analyses of temperature time series obtained within the first five days of life are associated with gestational age (GA) and body size at birth, and presence and severity of typical comorbidities of preterm birth.Entities:
Mesh:
Year: 2017 PMID: 28448569 PMCID: PMC5407818 DOI: 10.1371/journal.pone.0176670
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow of patients and measurements through the phases of the study.
Baseline characteristics of study participants.
| Variable | |
|---|---|
| Participants, n (% male) | 73 (64) |
| Gestational age at birth (weeks) | 30.05 (2.46) |
| Birth weight (g) | 1244 (337) |
| Birth weight z-score | -0.94 (1.07) |
| Weight loss in first week of life (%) | 2.35 (4.10) |
| Maximum level of respiratory support, n measurements (%) | |
Data are presented as mean (standard deviation) unless stated otherwise.
*Defined as no; suspected (CRP>20mg/ml, antibiotic treatment >5 days, histologically proven chorioamnionitis); proven (suspected plus positive blood cultures).
**Maximum grade (1 to 4) documented according to Papile classification [32].
Univariable, multilevel linear regression analyses of mean and coefficient of variation of body temperature.
| Tmean | Tcv | |||||||
|---|---|---|---|---|---|---|---|---|
| Variable | Coeff beta | p-value | 95% CI | R2 between; overall | Coeff beta | p-value | 95% CI | R2 between; overall |
| GA (weeks) | 0.012 | 0.183 | -0.006 to 0.031 | NA | -0.016 | 0.249 | -0.044 to 0.011 | NA |
| Weight (g) | <0.001 | 0.975 | <-0.001 to <0.001 | NA | <0.001 | 0.146 | <0.001 to <0.001 | NA |
| BW z-score | -0.034 | 0.117 | -0.076 to 0.008 | NA | -0.018 | 0.587 | -0.084 to 0.048 | NA |
| Weight loss (%) | <0.001 | 0.876 | -0.005 to 0.006 | NA | 0.002 | 0.796 | -0.011 to 0.014 | NA |
| Male gender | -0.012 | 0.805 | -0.219 to 0.032 | NA | 0.029 | 0.704 | -0.119 to 0.177 | NA |
| EOS | -0.115 | 0.081 | -0.244 to 0.014 | 7; 1 | 0.172 | 0.096 | -0.030 to 0.374 | 6; 2 |
| IVH | -0.123 | 0.186 | -0.306 to <-0.059 | NA | 0.063 | 0.673 | -0.358 to 0.231 | NA |
| Respiratory support | 0.070 | 0.380 | -0.087 to 0.227 | NA | 0.407 | 0.011 | 0.095 to 0.719 | 11%; 2% |
| Prone position | 0.007 | 0.860 | -0.072 to 0.086 | NA | -0.114 | 0.199 | -0.364 to 0.076 | 8%; 1% |
| Phototherapy | 0.132 | <0.001 | 0.084 to 0.179 | 8%; 10% | 0.250 | 0.001 | 0.102 to 0.398 | 8%; 4% |
| Time to last caffeine (h) | <-0.001 | 0.749 | -0.005 to 0.004 | NA | <-0.001 | 0.855 | -0.011 to 0.009 | NA |
| Duration (min) | -0.001 | 0.024 | -0.002 to <-0.001 | 7%; 3% | <-0.001 | 0.824 | -0.003 to 0.002 | NA |
| Perturbance | 0.082 | 0.342 | -0.087 to 0.250 | NA | 0.359 | 0.207 | -0.198 to 0.916 | NA |
| Time awake (%) | <-0.001 | 0.401 | -0.002 to 0.001 | NA | -0.005 | 0.017 | -0.009 to <-0,001 | 2%; 3% |
| Time active (%) | <-0.001 | 0.521 | -0.002 to 0.001 | NA | -0.005 | 0.031 | -0.010 to -0.001 | 6%; 3% |
| Duration SC (min) | 0.001 | 0.122 | <-0.001 to 0.003 | NA | 0.009 | 0.001 | 0.004 to 0.014 | 16%; 6% |
aLog-transformed to achieve normal distribution; GA: Gestational age; Weight: Weight at study; BW z-score: Birth weight z-score; Weight loss: % difference of birth weight and weight at study; EOS: Early onset sepsis (none; suspected; proven); IVH: Germinal matrix-intraventricular haemorrhage (none, grade 1–2 vs. grade 3–4); Respiratory support at study (none; continuous positive airway pressure; endotracheal ventilation); Phototherapy: Phototherapy during measurement due to hyperbilirubinaemia; Time to last caffeine: Time from last caffeine dose measured at start of observation (h); Duration: Duration of measurement (min); Perturbance: Perturbance score, i.e., number of open incubator doors x time of open incubator doors during measurement; Time awake: % of measurement spent awake; Time active: % of measurement spent awake or in active sleep; Duration SC: Average duration (min) of sleep cycles (reappearance of active sleep) within one measurement.
Univariable, multilevel linear regression analyses of scaling exponent alpha and sample entropy of body temperature.
| Talpha | TSampEna | |||||||
|---|---|---|---|---|---|---|---|---|
| Coeff beta | p-value | 95% CI | R2 between; overall | Coeff beta | p-value | 95% CI | R2 between; overall | |
| GA (weeks) | -0.026 | <0.001 | -0.036 to -0.015 | 23%; 9% | 0.054 | 0.007 | 0.015 to 0.094 | 9%; 3% |
| Weight (g) | <-0.001 | <0.001 | <-0.001 to | 30%; 14% | <0.001 | <0.001 | <0.001 to <0.001 | 16%; 5% |
| BW z-score | -0.017 | 0.254 | -0.046 to 0.012 | NA | 0.058 | 0.250 | -0.041 to 0.157 | NA |
| Weight loss (%) | -0.002 | 0.506 | -0.006 to 0.003 | NA | 0.004 | 0.621 | -0.013 to 0.022 | NA |
| Male gender | <-0.001 | 0.982 | -0.067 to 0.065 | NA | -0.102 | 0.349 | -0.319 to 0.113 | NA |
| EOS | 0.189 | <0.001 | 0.114 to 0.264 | 29%; 11% | -0.487 | 0.001 | -0.769 to -0.204 | 15%; 4% |
| IVH | -0.044 | 0.500 | -0.170 to 0.083 | NA | 0.399 | 0.065 | -0.025 to 0.822 | NA |
| Respiratory support | 0.274 | <0.001 | 0.161 to 0.387 | 29%; 14% | -0.759 | 0.001 | -1.192 to -0.327 | 15%; 5% |
| Prone position | -0.072 | 0.072 | -0.151 to 0.006 | 9%; 2% | 0.211 | 0.167 | -0.089 to 0.510 | NA |
| Phototherapy | 0.066 | 0.011 | 0.015 to 0.117 | 12%; 3% | -0.265 | 0.009 | -0.463 to -0.067 | 2%; 3% |
| Time to last caffeine (h) | -0.003 | 0.074 | -0.007 to <0.001 | 6%; 2% | 0.009 | 0.227 | -0.005 to 0.023 | NA |
| Duration (min) | <0.001 | 0.320 | <-0.001 to 0.001 | NA | <0.001 | 0.949 | -0.003 to 0.004 | NA |
| Perturbance | 0.107 | 0.276 | -0.085 to 0.299 | NA | -1.035 | 0.005 | -1.765 to -0.307 | 4%; 4% |
| Time awake (%) | -0.001 | 0.074 | -0.003 to <0.001 | 7%; 3% | 0.004 | 0.180 | -0.002 to 0.010 | NA |
| Time active (%) | <0.001 | 0.989 | -0.002 to 0.002 | NA | 0.005 | 0.210 | -0.003 to 0.012 | NA |
| Duration SC (min) | 0.003 | 0.001 | 0.001 to 0.005 | 3%; 7% | -0.012 | <0.001 | -0.018 to -0.005 | 11%; 8% |
Please refer to legend of Table 2.
Multivariable, multilevel linear regression analyses of all outcomes.
| Coeff | p-value | 95% CI | R2 between; overall | |
|---|---|---|---|---|
| Tmean | 27%; 16% | |||
| EOS (proven) | -0.139 | 0.019 | -0.256 to -0.023 | |
| Phototherapy | 0.141 | <0.001 | 0.092 to 0.191 | |
| Duration (min) | -0.002 | 0.001 | -0.002 to -0.001 | |
| Tcv | 19%; 9% | |||
| Phototherapy | 0.359 | 0.020 | 0.056 to 0.661 | |
| Duration SC | 0.007 | 0.013 | 0.001 to 0.012 | |
| Talpha | 38%; 19% | |||
| GA | -0.016 | 0.021 | -0.029 to -0.002 | |
| BW z-score | -0.044 | <0.001 | -0.069 to -0.020 | |
| Respiratory support | 0.205 | 0.003 | 0.071 to 0.339 | |
| TSampEn | 15%; 7% | |||
| GA | 0.065 | 0.002 | 0.023 to 0.106 | |
| BW z-score | 0.104 | 0.039 | 0.005 to 0.202 | |
| Phototherapy | -0.218 | 0.031 | -0.416 to -0.019 |
aLog-transformed to achieve normal distribution; GA: Gestational age; BW z-score: Birth weight z-score; EOS: early onset sepsis (none; suspected; proven); respiratory support at study (none; continuous positive airway pressure; endotracheal ventilation); Phototherapy: Phototherapy during measurement due to hyperbilirubinaemia; Duration: Duration of measurement (min); Duration SC: Average duration (min) of sleep cycles (reappearance of active sleep) within one measurement.
Fig 2Scaling exponent alpha (Talpha) over gestational age (GA).
Average Talpha over the first five days of life derived from detrended fluctuation analysis of temperature time series plotted against GA at birth. Multilevel linear regression analysis demonstrated a significant negative association between Talpha and GA at birth (p<0.001, R2 = 0.29).
Fig 3Scaling exponent alpha (Talpha) over respiratory support.
Talpha grouped by the level of respiratory support present during a temperature measurement. Multilevel linear regression analysis demonstrated a significant positive association between Talpha and stepwise increase of respiratory support from none to continuous positive airway pressure (CPAP), and from CPAP to endotracheal ventilation (p < 0.001, R2 = 0.29).
Fig 4Scaling exponent alpha (Talpha) over postnatal age.
Talpha decreased from a mean (SD) of 1.67 (0.18) on day one of life to 1.46 (0.22) on day five of life (p<0.001).
Sensitivity analysis related to amount and fragmentation of data.
| Variable | All acceptable parts | Single longest acceptable part | Mean diff (95%CI); p-value |
|---|---|---|---|
| Tmean | 37.0 (0.3) | 37.0 (0.3) | 0.0 (-0.02 to 0.02); p = 0.863 |
| Tcv | -66 (57) | -102 (61) | 36 (-116 to -81); p<0.001 |
| TSampEn | -1.58 (0.70) | -1.38 (0.76) | -0.20 (-0.35 to -0.06); p = 0.007 |
Data are presented as mean (standard deviation)
aLog-transformed to achieve normal distribution
bpaired t-test; CV: coefficient of variation; TSampEn: Sample entropy; Mean Diff: Difference of outcome comparing all technically acceptable parts vs. only the single longest technically acceptable part.